POU2AF1 and type 1 diabetes mellitus: Although its expression is 50- to 100-fold lower in T cells compared with B cells (31), targeting either OCA-B by genetic deletion in T cells or its downstream functions with a membrane-permeable peptide mimic suppresses type-1 diabetes (32).